These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1786916

  • 1. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [Abstract] [Full Text] [Related]

  • 2. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [Abstract] [Full Text] [Related]

  • 3. Thrombospondin: a new attachment protein in preretinal traction membranes.
    Weller M, Esser P, Bresgen M, Heimann K, Wiedemann P.
    Eur J Ophthalmol; 1992; 2(1):10-4. PubMed ID: 1353387
    [Abstract] [Full Text] [Related]

  • 4. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [Abstract] [Full Text] [Related]

  • 5. [Contractile elements in proliferative retinal diseases].
    Molitor R, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [Abstract] [Full Text] [Related]

  • 6. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM, Nawaz MI, Ola MS, De Hertogh G, Opdenakker G, Geboes K.
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [Abstract] [Full Text] [Related]

  • 7. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP, Kampik A.
    Fortschr Ophthalmol; 1991 May; 88(3):219-24. PubMed ID: 1889766
    [Abstract] [Full Text] [Related]

  • 8. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M, Esser P, Heimann K, Wiedemann P.
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E, Ioachim E, Stefaniotou M, Gorezis S, Charalabopoulos K, Bagli H, Peschos D, Psilas K, Agnantis NJ.
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [Abstract] [Full Text] [Related]

  • 10. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M, Esser P, Wiedemann P, Heimann K.
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [Abstract] [Full Text] [Related]

  • 11. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 12. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
    Heidenkummer HP, Kampik A, Petrovski B.
    Retina; 1992 Sep; 12(1):52-8. PubMed ID: 1565872
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin.
    Hiscott P, Larkin G, Robey HL, Orr G, Grierson I.
    Eye (Lond); 1992 Sep; 6 ( Pt 6)():566-9. PubMed ID: 1289132
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

  • 17. Management of proliferative diabetic retinopathy.
    Gündüz K, Bakri SJ.
    Compr Ophthalmol Update; 2007 Jul 15; 8(5):245-56. PubMed ID: 18201511
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG, Nicoletti R, Ferrara N, Meli G, Reibaldi M, Reibaldi A.
    Exp Clin Endocrinol Diabetes; 2003 Jun 15; 111(4):209-14. PubMed ID: 12845559
    [Abstract] [Full Text] [Related]

  • 20. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ, Spitznas M, Koch F, Grus F, Böker T.
    Ger J Ophthalmol; 1995 Jan 15; 4(1):47-51. PubMed ID: 7728110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.